Drugplain

Dr.Jucre Rebirth Sun Protection .04 g/100mL

OCTINOXATE, HOMOSALATE, OCTISALATE, AVOBENZONE, ENSULIZOLE, OCTOCRYLENE, BEMOTRIZINOL, NIACINAMIDE, ADENOSINE · CREAM · NATURECELL CO., LTD.

No Recall History
Plain English

Dr.Jucre Rebirth Sun Protection is a cream containing octinoxate, homosalate, octisalate, avobenzone, ensulizole, octocrylene, bemotrizinol, niacinamide, adenosine at .04 g/100mL, taken topical. Manufactured by NATURECELL CO., LTD..

Key Facts

Brand Name
Dr.Jucre Rebirth Sun Protection
Generic Name
OCTINOXATE, HOMOSALATE, OCTISALATE, AVOBENZONE, ENSULIZOLE, OCTOCRYLENE, BEMOTRIZINOL, NIACINAMIDE, ADENOSINE
NDC Code (Product)
83071-150
Manufacturer
NATURECELL CO., LTD.
Strength
.04 g/100mL
Dosage Form
CREAM
Route
TOPICAL
Marketing Status
Drug Class
Adenosine Receptor Agonist [EPC]
Marketing Start
11/30/2024

Recall History

No Recall History

Frequently Asked Questions

What is Dr.Jucre Rebirth Sun Protection used for?

Dr.Jucre Rebirth Sun Protection contains OCTINOXATE, HOMOSALATE, OCTISALATE, AVOBENZONE, ENSULIZOLE, OCTOCRYLENE, BEMOTRIZINOL, NIACINAMIDE, ADENOSINE. It is a cream taken topical. Consult your doctor for specific uses.

Is Dr.Jucre Rebirth Sun Protection a controlled substance?

Dr.Jucre Rebirth Sun Protection is not classified as a controlled substance by the DEA.

What is the generic name for Dr.Jucre Rebirth Sun Protection?

The generic name for Dr.Jucre Rebirth Sun Protection is OCTINOXATE, HOMOSALATE, OCTISALATE, AVOBENZONE, ENSULIZOLE, OCTOCRYLENE, BEMOTRIZINOL, NIACINAMIDE, ADENOSINE. There are no other listed brand versions of OCTINOXATE, HOMOSALATE, OCTISALATE, AVOBENZONE, ENSULIZOLE, OCTOCRYLENE, BEMOTRIZINOL, NIACINAMIDE, ADENOSINE.

What is the NDC code for Dr.Jucre Rebirth Sun Protection .04 g/100mL?

The NDC (National Drug Code) for Dr.Jucre Rebirth Sun Protection .04 g/100mL is 83071-150, listed by NATURECELL CO., LTD..

Product NDC

83071-150

Package NDC

83071-150-02

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)